News
New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...
Provider problems become patient problems when left unsolved. Five years after the swell of provider caseloads, some patients ...
Telehealth once promised something similarly transformative for healthcare. Free from geographical and logistical constraints ...
Stigma and logistical complications were major barriers in the successful implementation of the UCLA Homeless Healthcare Collaborative.
In a recent social media post, high-stakes poker pro Tom Dwan said he will be filing lawsuits after a recent stay in a ...
1d
HealthDay on MSNGLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, DepressionFor patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not ...
HealthDay News — For patients ... safety profile of GLP-1 RAs and suggest that GLP-1 RA treatment is associated with improved mental well-being, in addition to the known physical health ...
6d
Colchester Gazette on MSNTeenage pedestrian who died on A12 was on escorted leave from mental health unitA TEENAGER who was killed when she was hit by a vehicle on the A12 was on escorted leave from a mental health unit, an ...
The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effective, and non-drug treatment for depression "National TMS ...
Raghvendra Tripathi is a principal enterprise architect who has been working to change the face of public health in the U.S. by building systems that offer a more ...
- The exploratory, randomized, double-blind, placebo-controlled Phase 2 study will assess the safety, tolerability and efficacy of EMP-01 in adults with social anxiety disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results